Demis Hassabis' AI Company Isomorphic Labs Raises $5 Billion Following His Departure from Google DeepMind

Isomorphic Labs has secured $5 billion in its Series C funding round, a significant achievement that underscores the increasing confidence in AI's potential to transform drug discovery. This funding comes just months after Demis Hassabis stepped down as CEO of Google DeepMind, indicating a strategic shift towards his new venture.

The substantial investment reflects a broader trend in the pharmaceutical and biotech sectors, where AI technologies are being leveraged to enhance research and development processes. This influx of capital may accelerate Isomorphic Labs' initiatives in developing AI tools that can streamline drug discovery, potentially impacting the competitive landscape of the biotech industry

Stocks in this article

Company Price Change Change % AI
Google GOOGL.US 282.54 -1.18 -0.42% Sell

StockGuide AI model context

Google · Sell · Risk: 70/100 · Potential: 40/100 · 2026-11-16

More economy news